Multiple sclerosis genetics.
- Authors
- McElroy, J P; Oksenberg, J R
- Year
- 2008
- Journal
- Current topics in microbiology and immunology
- PMID
- 18219814
- DOI
- 10.1007/978-3-540-73677-6_3
Multiple sclerosis (MS) clusters with the so-called complex genetic diseases, a group of common disorders characterized by modest disease risk heritability and multifaceted gene-environment interactions. The major histocompatibility complex (MHC) is the only genomic region consistently associated with MS, and susceptible MHC haplotypes have been identified. Although the MHC does not account for all genetic contribution to MS, the other genetic contributors have been elusive. Microarray gene-expression studies, which also have not identified a major MS locus, have, however, been promising in elucidating some of the possible pathways involved in the disease. Yet, microarray studies thus far have been unable to separate the genetic causes of MS from the expression consequences of MS. The use of new methodologies and technologies to refine the phenotype, such as brain spectroscopy, PET and functional magnetic resonance imaging combined with novel computational tools and a better understanding of the human genome architecture, may help resolve the genetic causes of MS.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Evaluation of S100A12 and Apo-A1 plasma level potency in untreated new relapsing-remitting multiple sclerosis patients and their family members. | Samangooei M et al. | β | 2022 | β |
| Mesenchymal Stromal/Stem Cells Do Not Ameliorate Experimental Autoimmune Encephalomyelitis and Are Not Detectable in the Central Nervous System of Transplanted Mice. | Abramowski P et al. | β | 2016 | β |
| Immunomodulatory effects of the ether phospholipid edelfosine in experimental autoimmune encephalomyelitis. | Abramowski P et al. | β | 2014 | β |
| Tumor necrosis factor beta (TNF-Ξ²) NcoI polymorphism is associated with multiple sclerosis in Caucasian patients from Southern Brazil independently from HLA-DRB1. | Kallaur AP et al. | β | 2014 | β |
| Copy number variation in pediatric multiple sclerosis. | McElroy JP et al. | β | 2013 | β |
| Identification of a functional variant in the KIF5A-CYP27B1-METTL1-FAM119B locus associated with multiple sclerosis. | Alcina A et al. | β | 2013 | β |
| Putative association of GPC5 polymorphism with the risk of inflammatory demyelinating diseases. | Shin JG et al. | β | 2013 | β |
| Multiple sclerosis risk variant HLA-DRB1*1501 associates with high expression of DRB1 gene in different human populations. | Alcina A et al. | β | 2012 | β |
| Replication study of multiple sclerosis (MS) susceptibility alleles and correlation of DNA-variants with disease features in a cohort of Austrian MS patients. | Schmied MC et al. | β | 2012 | β |
| Cytokine gene polymorphisms in multiple sclerosis: a meta-analysis of 45 studies including 7379 cases and 8131 controls. | Nikolopoulos GK et al. | β | 2011 | β |
| Genomic regions identified by overlapping clusters of nominally-positive SNPs from genome-wide studies of alcohol and illegal substance dependence. | Johnson C et al. | β | 2011 | β |
| Interleukin 2 receptor Ξ± gene polymorphism and risk of multiple sclerosis: a meta-analysis. | Wang LM et al. | β | 2011 | β |
| Investigation of CD24 and its expression in Iranian relapsing-remitting multiple sclerosis. | Kollaee A et al. | β | 2011 | β |
| "Replicated" genome wide association for dependence on illegal substances: genomic regions identified by overlapping clusters of nominally positive SNPs. | Drgon T et al. | β | 2011 | β |
| SNP-based analysis of the HLA locus in Japanese multiple sclerosis patients. | McElroy JP et al. | β | 2011 | β |
| Genome wide association for addiction: replicated results and comparisons of two analytic approaches. | Drgon T et al. | β | 2010 | β |
| Hexose-6-phosphate dehydrogenase: a new risk gene for multiple sclerosis. | Alcina A et al. | β | 2010 | β |
| Multiple sclerosis genetics--is the glass half full, or half empty? | Oksenberg JR et al. | β | 2010 | β |
| Multiple sclerosis pharmacogenomics: maximizing efficacy of therapy. | Pappas DJ et al. | β | 2010 | β |
| Potential triggers of MS. | Libbey JE et al. | β | 2010 | β |
| Refining the association of MHC with multiple sclerosis in African Americans. | McElroy JP et al. | β | 2010 | β |
| Tag-SNP analysis of the GFI1-EVI5-RPL5-FAM69 risk locus for multiple sclerosis. | Alcina A et al. | β | 2010 | β |
| The autoimmune disease-associated KIF5A, CD226 and SH2B3 gene variants confer susceptibility for multiple sclerosis. | Alcina A et al. | β | 2010 | β |
| The role of non-HLA single nucleotide polymorphisms in multiple sclerosis susceptibility. | Bahreini SA et al. | β | 2010 | β |
| Association between protective and deleterious HLA alleles with multiple sclerosis in Central East Sardinia. | Pastorino R et al. | β | 2009 | β |
| Common variants in polygenic schizophrenia. | Glessner JT et al. | β | 2009 | β |
| IL2RA/CD25 gene polymorphisms: uneven association with multiple sclerosis (MS) and type 1 diabetes (T1D). | Alcina A et al. | β | 2009 | β |
| The HLA genomic loci map: expression, interaction, diversity and disease. | Shiina T et al. | β | 2009 | β |
| The genetics of multiple sclerosis: SNPs to pathways to pathogenesis. | Oksenberg JR et al. | β | 2008 | β |